Pharmacology, Toxicology and Biomedical Reports,2019,5,3s,ii.
The general administration of pharmaceutical care strategic planning founded during 2010- 2020 with an emphasis on Pharmacoeconomic and cost analysis related issues.1 The evaluation of the previous plan and updated of pharmacy strategic plan with new Saudi vision 2030 released in 2018 included the cost analysis of pharmacy services and cost avoidance of impact clinical pharmacy services.2 Within a short time, several publications discussed the necessary foundations of Pharmacy services. The cost was demandable to quantify the services and calculated as cost expenditures to determine the new economic income from each pharmacy service. Also, to estimate the impact of cost avoidance of pharmacy services provided to the patient. Several methods used to calculate the cost of pharmacy services. The conventional techniques were calculated the time spent with each clinical activity and salary paid to the pharmacist. The other method used for cost calculation was determined the fixed cost including personal cost, material and supply cost, fixed expenses including direct cost, nonsalary cost and overhead cost. All price was used US dollar currency. The cost impact or avoidance method was from drug-related morbidity and mortality cost avoidance. The technique is widely used in local or international researches.